WIA
RLMD icon

World Investment Advisors’s Relmada Therapeutics RLMD Stock Holding History

World Investment Advisors’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.7K Hold
10,444
– – ﹤0.01% 1506
2026
Q1 		$72.7K Hold
10,444
– – ﹤0.01% 1542
2025
Q4 		$50.4K Sell
10,444
-200
-2% -$670 ﹤0.01% 1452
2025
Q3 		$21.4K Sell
10,644
-11,000
-51% -$10.6K ﹤0.01% 1231
2025
Q2 		$13K Hold
21,644
– – ﹤0.01% 1126
2025
Q1 		$5.84K Sell
21,644
-8,040
-27% -$2.67K ﹤0.01% 1047
2024
Q4 		$15.4K Sell
29,684
-3,000
-9% -$7.32K ﹤0.01% 999
2024
Q3 		$106K Buy
32,684
+2,000
+7% +$6.48K ﹤0.01% 887
2024
Q2 		$92.1K Hold
30,684
– – 0.01% 612
2024
Q1 		$143K Buy
+30,684
New +$148K 0.02% 386
2022
Q4 		– Sell
-12,700
Closed -$470K – 266
2022
Q3 		$470K Hold
12,700
– – 0.11% 137
2022
Q2 		$312K Sell
12,700
-1,500
-11% -$32.7K 0.07% 191
2022
Q1 		$383K Hold
14,200
– – 0.08% 172
2021
Q4 		$263K Hold
14,200
– – 0.06% 220
2021
Q3 		$372K Buy
14,200
+200
+1% +$5.35K 0.08% 167
2021
Q2 		$448K Sell
14,000
-500
-3% -$17.4K 0.1% 139
2021
Q1 		$486K Sell
14,500
-1,650
-10% -$57.7K 0.12% 119
2020
Q4 		$589K Sell
16,150
-350
-2% -$12K 0.15% 110
2020
Q3 		$621K Sell
16,500
-400
-2% -$15.5K 0.21% 74
2020
Q2 		$630K Buy
16,900
+2,900
+21% +$123K 0.22% 70
2020
Q1 		$478K Buy
14,000
+1,000
+8% +$40.3K 0.22% 70
2019
Q4 		$507K Buy
+13,000
New +$395K 0.2% 71

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

World Investment Advisors's RLMD Position: Q2 2026 in Review

World Investment Advisors held its Relmada Therapeutics (RLMD) position steady in Q2 2026 at 10,444 shares worth $72.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1506.

World Investment Advisors first reported a position in RLMD in Q4 2019 and has held it in 22 quarters since. The position peaked at $630K in Q2 2020. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • World Investment Advisors held 10,444 shares of Relmada Therapeutics worth $72.7K as of Q2 2026.
  • World Investment Advisors left its Relmada Therapeutics share count unchanged in Q2 2026.
  • Relmada Therapeutics made up ﹤0.01% of World Investment Advisors's portfolio in Q2 2026, its #1506 holding.
  • World Investment Advisors first reported a position in Relmada Therapeutics in Q4 2019 and has held it in 22 quarters since.
  • World Investment Advisors's Relmada Therapeutics position peaked at $630K in Q2 2020.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.